Neurovascular Embolization Market Share

Report ID: GMI7160
   |
Published Date: October 2023
 | 
Report Format: PDF

Download Free PDF

Neurovascular Embolization Market Share

The neurovascular embolization industry is consolidated, with key players such as Medtronic, Stryker, Cerenovus (Johnson & Johnson), and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, Medtronic's pipeline flex embolization device with shield technology has received FDA approval. This technology is a notable advancement in flow diversion therapy, reducing the risk of clot formation on the device's surface and improving treatment safety and efficacy.
 

Some of the eminent market participants operating in the neurovascular embolization industry include:

  • Medtronic
  • Stryker
  • Cerenovus (Johnson & Johnson)
  • Integra LifeSciences
  • Penumbra Inc
  • Balt SAS
  • B. Braun Melsungen AG
  • Phenox GmbH
  • MicroVention Inc (Terumo Corporation)
  • Shape Memory Medical Inc
  • Peter Lazic GmbH
  • Spartan Micro
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
What is the size of Neurovascular Embolization Market?
The global neurovascular embolization industry was valued at USD 1.4 billion in 2022 and is estimated to account for USD 2.5 billion by 2032.
Why are embolic coils witnessing demand in neurovascular embolization industry?
Who are the key contenders in neurovascular embolization industry?
How big is the U.S. neurovascular embolization industry?
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2022

    Companies covered: 12

    Tables & Figures: 287

    Countries covered: 18

    Pages: 207

    Download Free PDF

    Top